Table 2

- Multivariate analysis of prognostic factors for progression-free survival and overall survival in 32 patients with diffuse large B-cell lymphoma of the breast

FactorsProgression-free survivalOverall survival
HR95% CIP-valuesHR95%CIP-values
Ann Arbor stage (III-IV, I-II)2.180.20-23.330.5193.750.39-36.150.25
B symptoms (Yes, No)3.340.55-20.460.193.600.54-24.080.19
Recurrence (Yes, No)10.991.16-104.370.037*7.590.87-66.130.066
  • * P-value of <0.05 was significant. HR: hazard ratio, CI: confidence interval